GSTM2: Key Regulator of Glucose Homeostasis (G2946)

Target Name: GSTM2

NCBI ID: G2946

GSTM2

GSTM2: Key Regulator of Glucose Homeostasis

GSTM2 (GST-M2) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a key regulator of the glucose homeostasis, which is the balance between the glucose levels in the blood and the glucose that is used by the cells for energy.

GSTM2 is a member of the GST family of transmembrane proteins, which are involved in the transfer of genetic information from the cell body to the cell surface. GSTM2 is composed of an extracellular region, a transmembrane region, and an intracellular region. The transmembrane region of GSTM2 is composed of four transmembrane domains: a N-terminal domain, a T-terminal domain, a middle domain, and a C-terminal domain.

The N-terminal domain of GSTM2 is rich in amino acids that are involved in the formation of the transmembrane region. The T-terminal domain is involved in the formation of the extracellular region, which is involved in the formation of the protein's correct and durable activity. The middle domain is involved in the formation of the intracellular region, which is involved in the regulation of the protein's stability and the interaction with other cellular components. The C-terminal domain is involved in the formation of the transmembrane region and is involved in the regulation of the protein's stability.

GSTM2 is involved in the regulation of a wide range of cellular processes, including the regulation of glucose metabolism, the regulation of cell adhesion, and the regulation of neurotransmitter release. It is also involved in the regulation of cellular signaling pathways, including the regulation of the DNA damage response and the regulation of the cell cycle.

GSTM2 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. It is also been shown to be involved in the regulation of various biological processes, including the regulation of metabolism, cell growth, and inflammation.

GSTM2 is a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. It is also a potential biomarker for the diagnosis and prognosis of these diseases.

GSTM2 is a protein that is involved in the regulation of a wide range of cellular processes, including the regulation of glucose metabolism, the regulation of cell adhesion, and the regulation of neurotransmitter release. It is also involved in the regulation of cellular signaling pathways, including the regulation of the DNA damage response and the regulation of the cell cycle. It is a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases, and it is also a potential biomarker for the diagnosis and prognosis of these diseases.

Protein Name: Glutathione S-transferase Mu 2

Functions: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Participates in the formation of novel hepoxilin regioisomers (PubMed:21046276)

The "GSTM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GSTM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets